Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2019 | 2 |
2021 | 2 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Synthetic lethality of drug-induced polyploidy and BCL-2 inhibition in lymphoma.
Nat Commun. 2023 Mar 18;14(1):1522. doi: 10.1038/s41467-023-37216-2.
Nat Commun. 2023.
PMID: 36934096
Free PMC article.
TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma.
Erazo T, Evans CM, Zakheim D, Chu KL, Refermat AY, Asgari Z, Yang X, Da Silva Ferreira M, Mehta S, Russo MV, Knezevic A, Zhang XP, Chen Z, Fennell M, Garippa R, Seshan V, de Stanchina E, Barbash O, Batlevi CL, Leslie CS, Melnick AM, Younes A, Kharas MG.
Erazo T, et al. Among authors: da silva ferreira m.
Nat Commun. 2022 Sep 27;13(1):5676. doi: 10.1038/s41467-022-33137-8.
Nat Commun. 2022.
PMID: 36167829
Free PMC article.
Item in Clipboard
Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition.
Bala Tannan N, Manzari MT, Herviou L, Da Silva Ferreira M, Hagen C, Kiguchi H, Manova-Todorova K, Seshan V, de Stanchina E, Heller DA, Younes A.
Bala Tannan N, et al. Among authors: da silva ferreira m.
Blood. 2021 Apr 15;137(15):2057-2069. doi: 10.1182/blood.2020008017.
Blood. 2021.
PMID: 33067607
Free PMC article.
Item in Clipboard
ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors.
Portelinha A, Thompson S, Smith RA, Da Silva Ferreira M, Asgari Z, Knezevic A, Seshan V, de Stanchina E, Gupta S, Denis L, Younes A, Reddy S.
Portelinha A, et al. Among authors: da silva ferreira m.
Cell Rep Med. 2021 Jul 21;2(7):100350. doi: 10.1016/j.xcrm.2021.100350. eCollection 2021 Jul 20.
Cell Rep Med. 2021.
PMID: 34337566
Free PMC article.
Item in Clipboard
Stem cell mutations can be detected in myeloma patients years before onset of secondary leukemias.
Sridharan A, Schinke CD, Georgiev G, Da Silva Ferreira M, Thiruthuvanathan V, MacArthur I, Bhagat TD, Choudhary GS, Aluri S, Chen J, Pradhan K, Xia Y, Panjikaran M, Sims G, Bhagat CK, Bender R, Keeler L, Graber A, Heuck C, Fletcher FA, Alapat D, Weinhold N, Johnson SK, Wickrema A, Barlogie B, Morgan GJ, Shastri A, Steidl U, Will B, Verma A.
Sridharan A, et al. Among authors: da silva ferreira m.
Blood Adv. 2019 Dec 10;3(23):3962-3967. doi: 10.1182/bloodadvances.2019000731.
Blood Adv. 2019.
PMID: 31805192
Free PMC article.
Item in Clipboard
Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes.
Santini V, Valcárcel D, Platzbecker U, Komrokji RS, Cleverly AL, Lahn MM, Janssen J, Zhao Y, Chiang A, Giagounidis A, Guba SC, Gueorguieva I, Girvan AC, da Silva Ferreira M, Bhagat TD, Pradhan K, Steidl U, Sridharan A, Will B, Verma A.
Santini V, et al. Among authors: da silva ferreira m.
Clin Cancer Res. 2019 Dec 1;25(23):6976-6985. doi: 10.1158/1078-0432.CCR-19-1338. Epub 2019 Sep 3.
Clin Cancer Res. 2019.
PMID: 31481511
Clinical Trial.
Item in Clipboard
Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia.
Will B, Vogler TO, Narayanagari S, Bartholdy B, Todorova TI, da Silva Ferreira M, Chen J, Yu Y, Mayer J, Barreyro L, Carvajal L, Neriah DB, Roth M, van Oers J, Schaetzlein S, McMahon C, Edelmann W, Verma A, Steidl U.
Will B, et al. Among authors: da silva ferreira m.
Nat Med. 2015 Oct;21(10):1172-81. doi: 10.1038/nm.3936. Epub 2015 Sep 7.
Nat Med. 2015.
PMID: 26343801
Free PMC article.
Item in Clipboard
Cite
Cite